These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15505140)

  • 1. Hallucinations and sleep disturbances in Parkinson's disease.
    Kulisevsky J; Roldan E
    Neurology; 2004 Oct; 63(8 Suppl 3):S28-30. PubMed ID: 15505140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of nocturnal disturbances and excessive daytime sleepiness in Parkinson's disease.
    Barone P; Amboni M; Vitale C; Bonavita V
    Neurology; 2004 Oct; 63(8 Suppl 3):S35-8. PubMed ID: 15505142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When a Parkinson's disease patient starts to hallucinate.
    Poewe W
    Pract Neurol; 2008 Aug; 8(4):238-41. PubMed ID: 18644910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visual hallucinations as REM sleep behavior disorders in patients with Parkinson's disease.
    Nomura T; Inoue Y; Mitani H; Kawahara R; Miyake M; Nakashima K
    Mov Disord; 2003 Jul; 18(7):812-7. PubMed ID: 12815661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinations and REM sleep behaviour disorder in Parkinson's disease: dream imagery intrusions and other hypotheses.
    Manni R; Terzaghi M; Ratti PL; Repetto A; Zangaglia R; Pacchetti C
    Conscious Cogn; 2011 Dec; 20(4):1021-6. PubMed ID: 21071244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for visual hallucinations in patients with Parkinson's disease.
    Gama RL; de Bruin VM; de Bruin PF; Távora DG; Lopes EM; Jorge IF; Bittencourt LR; Tufik S
    Neurol Res; 2015 Feb; 37(2):112-6. PubMed ID: 25002179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approaching disturbed sleep in late Parkinson's Disease: first step toward a proposal for a revised UPDRS.
    Askenasy JJ
    Parkinsonism Relat Disord; 2001 Oct; 8(2):123-31. PubMed ID: 11489677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What we have learned about sleep disorders and psychosis after nearly two centuries of Parkinson's disease. Summary and conclusions.
    Fernandez HH
    CNS Spectr; 2008 Mar; 13(3 Suppl 4):34-5. PubMed ID: 18323765
    [No Abstract]   [Full Text] [Related]  

  • 9. Psychosis in Parkinson's disease.
    Wint DP; Okun MS; Fernandez HH
    J Geriatr Psychiatry Neurol; 2004 Sep; 17(3):127-36. PubMed ID: 15312276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric aspects of Parkinson's disease--an update.
    Schrag A
    J Neurol; 2004 Jul; 251(7):795-804. PubMed ID: 15258780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion.
    Belaid H; Adrien J; Laffrat E; Tandé D; Karachi C; Grabli D; Arnulf I; Clark SD; Drouot X; Hirsch EC; François C
    J Neurosci; 2014 Jul; 34(27):9124-33. PubMed ID: 24990932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Psychotic symptoms in Parkinson's disease].
    Fénelon G
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4 Spec No 1():S17-24. PubMed ID: 23631044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sleep disturbances in Parkinson's disease: characteristics, evaluation and therapeutic approaches].
    Faludi B; Janszky J; Komoly S; Kovács N
    Orv Hetil; 2015 Jul; 156(27):1091-9. PubMed ID: 26122904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beneficial effect of donepezil on visual hallucinations in three patients with Parkinson's disease.
    Kurita A; Ochiai Y; Kono Y; Suzuki M; Inoue K
    J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):184-8. PubMed ID: 12967063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep disturbances in Parkinsonism.
    Askenasy JJ
    J Neural Transm (Vienna); 2003 Feb; 110(2):125-50. PubMed ID: 12589574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between visual hallucinations and REM sleep behavior disorder in patients with Parkinson's disease.
    Meral H; Aydemir T; Ozer F; Ozturk O; Ozben S; Erol C; Cetin S; Hanoglu L; Ozkayran T; Yilsen M
    Clin Neurol Neurosurg; 2007 Dec; 109(10):862-7. PubMed ID: 17913346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between dopaminergic medications and nocturnal sleep in early-stage Parkinson's disease.
    Chahine LM; Daley J; Horn S; Duda JE; Colcher A; Hurtig H; Cantor C; Dahodwala N
    Parkinsonism Relat Disord; 2013 Oct; 19(10):859-63. PubMed ID: 23751512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Features associated with the development of hallucinations in Parkinson's disease.
    Benbir G; Ozekmekçi S; Cinar M; Beskardes F; Apaydin H; Erginöz E
    Acta Neurol Scand; 2006 Oct; 114(4):239-43. PubMed ID: 16942542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallucinations, REM sleep, and Parkinson's disease: a medical hypothesis.
    Arnulf I; Bonnet AM; Damier P; Bejjani BP; Seilhean D; Derenne JP; Agid Y
    Neurology; 2000 Jul; 55(2):281-8. PubMed ID: 10908906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology and treatment of psychosis in Parkinson's disease: a review.
    Zahodne LB; Fernandez HH
    Drugs Aging; 2008; 25(8):665-82. PubMed ID: 18665659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.